FFF yields 9.70% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, FFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FFF + PFE for your $10,000?
FFF is designed for investors with a long-term time horizon by targeting founder-led companies. The fund seeks capital appreciation, believing these companies offer superior risk-adjusted returns. The fund defines founder-led companies to be managed by a founder serving as a Chief Officer (CEO, CTO, CSO or CMO). Using a proprietary, rules-based process, it selects 100 of the largest 200 founder-led firms using market-cap and other fundamental factors. It considers market highs and lows to navigate market cycles and remove emotional decision making. Except for technology, FFF does not intend to concentrate in any single sector and may invest in firms of any size. The fund may invest in non-US companies, provided they are listed on a US exchange. The market cap-weighted portfolio limits single security exposure to 7.5%. The actively managed portfolio is rebalanced and reconstituted quarterly.
Full FFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.